• OVPR

    The Office of the Vice President for Research facilitates collaborative research opportunities, streamlines related policies and procedures, and acts as a unified voice for U of I research.

  • UIC OTM

    The Office of Technology Management at Chicago is responsible for managing the intellectual property generated by research and educational activities at the University.

  • UIC Research Center

    Supplies a fully-equipped infrastructure and access to University resources, internship programs, world-class talent, and custom-designed business development services.

  • UI Research Park

    Provides an ideal environment for starting a high-growth technology venture, with wet-chemistry labs, office space, an array of shared equipment, server co-location facilities, and conference rooms.

  • IllinoisVENTURES

    IllinoisVENTURES is a seed and early-stage technology investment firm focused on research-derived companies in information technologies, physical sciences and life sciences, with a particular emphasis on those deriving from research conducted at the University of Illinois and other regional research institutions and federal laboratories.

Office of Technology Management, Urbana-Champaign

Technologies

Other Categories

  • Energy/Environment
  • Energy Active
  • Energy Passive
  • Engineering
  • Electronics
  • Optics
  • Life Sciences Non-Health
  • Greater Good
  • Software

Disease Model

Mouse model for mutant allele of the cell cycling inhibitor BARA in mice.
Chicago, NONE OF THESE, NONE OF THESE, Disease Model, Research Tools and Reagants
A transgenic mouse model of pulmonary arterial hypertension (PAH).
Over a quarter of a million individuals a year are hospitalized for pulmonary arterial hypertension (PAH). Survival rates of these patients are typically less than 3 years post diagnosis and there is currently no cure or tractable animal model for PAH. Researchers in Pediatrics at UIC have developed an animal model by crossing two strains of mice with conditional transgenes.
Chicago, Circulatory, Pulmonary, Disease Model
Mutations Of MDR1 P-Glycoprotein That Improve Its Ability To Confer Resistance To Chemotherapeutic
The development of drug resistance in tumor cells is a major obstacle to clinical response in cancer
Chicago, NONE OF THESE, NONE OF THESE, Oncologic, Disease Model, Research Tools and Reagants
Innovative Computational Techniques for Identification of Novel T-cell Epitopes
Disease associated proteins are broken down by the cellular proteolytic machinery. Antigen-specific
ALL OF THESE, Chicago, Infectious, NONE OF THESE, NONE OF THESE, Disease Model, Research Tools and Reagants
print